When a medical device harms hundreds or thousands of patients, the first question lawyers ask is not whether the claims are serious. It is how the claims should be grouped. A class action and a mass tort are both ways to handle many claims at once, but they do different jobs. A defective medical device case usually fits the mass tort model because the patients are not identical. They may share the same product, but they do not share the same injury, medical history, recovery, or financial loss.
A class action treats a group as one legal unit. One or a few named plaintiffs represent everyone in the class. The court must approve the group, the claims, and any settlement. Class actions work best when the key facts are the same for everyone. A common example is a company charging an illegal fee to every customer on the same date. Everyone paid the same fee, lost the same amount, and can be identified from the company’s records. The court can decide the case once and apply the result to the whole group. Individual differences are small enough that they do not change the core dispute.
A mass tort is different. It is not one giant lawsuit with one representative for all. It is a group of individual claims that are coordinated for practical reasons. The cases may be filed in the same court, handled by the same judge for early stages, and share evidence about the product’s design, testing, marketing, and warnings. But each patient still has to prove that the device caused that patient’s injury and that the injury produced specific losses. That is why mass torts are common in defective hip implants, mesh, pacemakers, and other medical products.
The reason is simple: medical harm is personal. Two patients can receive the same implant and have very different outcomes. One may need one revision surgery and recover quickly. Another may suffer infection, nerve damage, lost wages, and years of pain. One may have a history that makes the link harder to prove. Another may have a strong record of good health before the implant. A class action would force those different claims into one bundle, and that can be unfair. A patient with a small claim might not get enough attention. A patient with a large claim might be limited by a settlement designed for the average class member.
Mass torts handle that problem by keeping claims separate while sharing the work. The court may create a leadership group of lawyers, set up a process for common evidence, and select a few cases for early trials. Those early trials help both sides see how juries react. They can push settlement talks. But the remaining patients are not automatically bound by one verdict in the same way class members are. Their cases still stand on their own facts.
That does not mean mass torts are always better. They can be slower, more expensive, and harder for an individual to pursue without a lawyer. They can also produce different results for similar patients. Class actions can be faster and cheaper, and they can give small claims a way to be heard together. The choice depends on how much the claims have in common and how much they differ.
Courts look at whether common questions dominate the case. If the same conduct caused the same kind of loss for everyone, a class action may be appropriate. If liability and damages depend on each patient’s body, treatment, and financial situation, a mass tort is usually the better fit. A defective medical device claim often lands there. The product may be common, but the harm is not. The law lets the patients share evidence and courtroom resources without pretending their injuries are identical.
For an injured patient, the label matters less than the practical result. The goal is to prove liability and recover for medical bills, lost income, pain, and other losses. The structure should not hide individual harm or force a patient into a settlement that does not fit. That is the real test in any mass tort versus class action question.
